What a blend actually is
A blend is two or more peptides lyophilized together in a single vial at a fixed ratio, rather than supplied separately and combined at the bench. That is a manufacturing decision with real research consequences, and it is worth understanding them before choosing one.
The case for a fixed ratio
The argument for co-formulation is consistency. Combining two reconstituted solutions by hand introduces pipetting error on every preparation, and that error is a source of variance between runs that has nothing to do with the biology. A blend fixes the ratio at manufacture, so every vial is identical and the only variable left is the volume of water added.
It also simplifies verification. A blend is tested as a finished vial, so the certificate reflects what is actually in the container rather than what was in two separate containers before someone mixed them.
The case against
The cost is the loss of independent variation, and it is not a small one. With separate vials a study can vary one component while holding the other constant, which is the only way to attribute an effect to one of them. With a blend the ratio is fixed, so any observed result belongs to the combination as a whole.
That makes blends well suited to work where the combination itself is the subject, and poorly suited to dose-ranging or attribution studies. A protocol asking “what does compound A contribute” should use separate vials. A protocol asking “what does this established pairing do” can reasonably use a blend.
The pairings we stock, and why they exist
Each blend reflects a combination that recurs in the literature rather than an arbitrary mixture.
BPC-157 + TB-500 is the standard tissue-repair pairing, studied for complementary mechanisms — see BPC-157 vs TB-500 for how they differ.
CJC-1295 (no DAC) + Ipamorelin pairs a GHRH-receptor agonist with a ghrelin-receptor agonist. The two reach the growth-hormone axis through separate receptors, which is exactly why they are combined: the question is whether the axis responds additively.
Cagrilintide + Semaglutide combines amylin and GLP-1 signalling — again two independent pathways converging on related endpoints.
GLOW and KLOW combine GHK-Cu with repair peptides, KLOW adding KPV for its inflammatory and gut-barrier literature.
Reconstituting a blend
Procedurally a blend reconstitutes exactly like a single-compound vial. The one difference worth noting is arithmetic: because the ratio is fixed at manufacture, the concentration of each component follows directly from the total volume added, so a target concentration for one component determines the concentration of the other. The reconstitution calculator handles it.
Identity and verification
The lot we currently hold measured 99.76% for the 10 mg + 10 mg (lot 261807) and 99.50% for the 10 mg + 10 mg (alt lot) (lot BPCTB012), tested by Freedom Diagnostics and Vanguard Laboratory (ISO 17025 accredited). The certificate is published in full, including the raw chromatogram and mass spectrum — so the number can be read off the underlying trace rather than taken on trust.
We use two laboratories because purity and identity are different questions. Vanguard Laboratory is ISO/IEC 17025:2017 accredited (A2LA #6377.01.01) and reports chromatographic purity and net quantity with a stated measurement uncertainty. Freedom Diagnostics reports HPLC-UV purity together with LC-MS identity confirmation — the test that catches a substituted compound rather than merely an impure one. A sample can be 99% pure and still be the wrong molecule. How we test →
Handling, reconstitution and storage
peptide blends ships lyophilized — freeze-dried to a solid and sealed under vacuum — which is what makes it stable in transit rather than a solution racing a clock. Reconstitute with bacteriostatic water, added slowly down the inside wall of the vial rather than directly onto the powder, then swirled gently. Do not shake: mechanical shear is one of the few things that reliably degrades a peptide in the lab.
Final concentration is a function of the volume added, not of the compound, so the same vial can be prepared at very different concentrations. The reconstitution calculator works out the volume for a target concentration and the reconstitution guide covers the procedure. Store lyophilized vials at −20 °C (−4 °F) protected from light; refrigerate once in solution, and see the storage and stability guide for how long reconstituted material holds.
Common questions
What is a peptide blend?
Two or more peptides lyophilized together in a single vial at a fixed ratio, rather than supplied separately and combined at the bench.
Why use a blend instead of separate vials?
Consistency. Combining two solutions by hand introduces pipetting error on every preparation, which adds variance unrelated to the biology. A blend fixes the ratio at manufacture, and is tested as a finished vial so the certificate reflects what is actually in the container.
When is a blend the wrong choice?
Whenever the study needs to vary one component independently. A fixed ratio means any result belongs to the combination as a whole, so dose-ranging and attribution studies need separate vials.
How is a blend reconstituted?
Exactly like a single-compound vial. The only difference is arithmetic — the ratio is fixed, so the total volume added determines the concentration of every component at once.
Are blends tested as a finished product?
Yes. The certificate is for the finished vial rather than for the separate inputs, so it reflects what is actually in the container. All certificates are published in full.
Where to get it
Buy research-grade peptide blends — independently tested, certificate published, shipped from Miami with cold-chain packaging. Current pricing for every size is on the price list, and we ship worldwide.
Research use only
Everything referenced here is supplied strictly for laboratory research. These compounds are not drugs, foods, cosmetics or medical devices, are not for human or veterinary use, and are not approved for diagnostic or therapeutic application. Mechanisms are described as studied in preclinical and laboratory research; nothing above describes dosing, treatment or clinical outcome.
